Cerenome (CNSY) news
Recent news
Cerenome gets in-network pact with Michigan BCBS
Cerenome has reached an in-network agreement with Blue Cross Blue Shield of Michigan, expanding access to its diagnostic services for policyholders in the state. This agreement follows a broader trend of partnerships between diagnostic firms and major insurers to enhance patient access to…
AInvest Wire · Sep 22, 2026Cerenome appoints Samantha Fowlkes as vice president and head of commercial sales, CNSide diagnostics division
AInvest Wire · Sep 16, 2026Cerenome: Proceeds to fund Conside commercial scale-up
Cerenome Inc. (NASDAQ: CERI) has announced that it will utilize recent proceeds to support the commercial scale-up of its product, Conside. The company disclosed that the funding will be allocated toward manufacturing expansion, regulatory compliance, and market access initiatives, all aimed at…
AInvest Wire · Sep 10, 2026Cerenome extends cash runway into 2028 with new financing
AInvest Wire · Sep 10, 2026Cerenome cluses up to $20M sentor secured facility with 31
Cerenome Inc. has secured a $20 million senior secured facility with 31, a financial agreement that provides the biotechnology company with additional capital to support its operations and development initiatives. The funding arrangement is expected to enhance Cerenome’s financial flexibility and…
AInvest Wire · Sep 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.